The Medicines and Healthcare Products Regulatory Agency (MHRA) has issued a recall notice to Allergen Limited. The recall notice relates to 5g and 3.5g pack sizes of
USFDA (Food and Drug Administration) issues import ban for products manufactured by Polydrug Laboratories. It was issued on Sept. 11, 2015 for
Health Canada has lifted its ban from Apotex two Indian facilities. Canada’s drug regulator reinspected the two plants in June and determined
Recently Karnataka drug control department had conducted surprise inspections to pick up drug samples at random. The drug test labs have issued their result.
Vivimed Labs has recently successfully completed inspection of its API manufacturing facility in Spain. After the completion of inspection Vivimed said “the USFDA inspectors concluded
GMP News & Guidelines Archives:
Vexim is a medical device company created in February 2006. Recently Brazil's National Health Surveillance Agency (Agência Nacional de Vigilância Sanitária or ANVISA) inspected Vexim to check its compliance with GMP standards. After the inspection, Brazil's National Health Surveillance Agency (Agência Nacional de Vigilância Sanitária or ANVISA) on February 19, 2015 announces a successful completion of GMP (Good Manufacturing Practices) inspection of the company without any non-compliance. Successful inspection of Vexim proves that the company maintains quality, safety and efficacy of all production steps and also of the finished product. This successful inspection will enable Vexim to grow its international business and opens a new marketing opportunity for Vexim in Latin America. The Company is now expecting to initiate export to Brazil by the end of 2015, after the result announcement of the product’s evaluation process.